Review



afp  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems afp
    Afp, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 131 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+afp/Human%2FMouse+alpha-Fetoprotein%2FAFP+Antibody/pm42988810-359-38-42
    Average 93 stars, based on 131 article reviews
    afp - by Bioz Stars, 2026-11
    93/100 stars

    Images

    Related Articles

    other:

    Article Title: DPPA2/4 Promote the Pluripotency and Proliferation of Bovine Extended Pluripotent Stem Cells by Upregulating the PI3K/AKT/GSK3β/β-Catenin Signaling Pathway
    Article Snippet: The primary antibodies used were as follows: anti-DPPA2 (ab91318; Abcam, Cambridge, UK), anti-DPPA4 (ab154642; Abcam, Cambridge, UK), anti-OCT4 (sc-9081; Santa Cruz Biotechnology, Shanghai, China), anti-SOX2 (4900s; Cell Signaling Technology, Boston, MA, USA), anti-NANOG (500-P236; PeproTech, London, UK), anti-GFAP (Z0334; Dako, Carpinteria, CA, USA), anti-AFP (MAB1368; R&D Systems, Minneapolis, MN, USA), anti-α-SMA (ab5694; Abcam, Cambridge, UK), anti-CDX2 (MU392A-UC; Biogenex, San Francisco, CA, USA), anti-SSEA1 (MAB4301; Santa Cruz Biotechnology, Dallas, TX, USA), and anti-SSEA4 (MAB4304; Santa Cruz Biotechnology, Dallas, TX, USA).

    Article Title: Mixed-Lineage Leukemia 1 Inhibition Enhances the Differentiation Potential of Bovine Embryonic Stem Cells by Increasing H3K4 Mono-Methylation at Active Promoters
    Article Snippet: The antibodies used in this experiment included anti-α-SMA (ab244177, Abcam, Cambridge, MU, USA), anti-AFP (MAB1368, R&D Systems, Minneapolis, MN, USA) and anti-GFAP (Z0334, DAKO, Copenhagen, Denmark).

    Article Title: Derivation of Arbas Cashmere Goat Induced Pluripotent Stem Cells in LCDM with Trophectoderm Lineage Differentiation and Interspecies Chimeric Abilities
    Article Snippet: The primary antibodies were as follows: anti-NANOG (1:200; 500-P236, Peprotech); anti-SSEA1 (1:200; MAB4301, Santa Cruz Biotechnology, Dallas, TX, USA); anti-SSEA4 (1:200; MAB4304, Santa Cruz Biotechnology, Dallas, TX, USA); anti-EpCAM (1:200; ab71916, Abcam, Cambridge, UK); anti-CDX2 (1:200; #MU392A-UC, Biogenex, San Francisco, CA, USA); anti-AFP (1:200; MAB1368, R&D Systems, Minneapolis, MN, USA); anti-alpha smooth muscle actin (1:200; ab5694, Abcam, Cambridge, UK); anti-glial fibrillary acidic protein (1:200; Z0334, Dako, Carpinteria, CA, USA); anti-KRT18 (1:200; F4772, Sigma-Aldrich, St. Louis, MO, USA); anti-PL (1:200; ab15554, Abcam, Cambridge, UK); anti-TEAD4 (1:200; 12418-1-AP, Proteintech, Rosemont, IL, USA); and anti-human CK7 (1:200; M7018, Dako, Carpinteria, CA, USA).

    Article Title: Derivation of Arbas Cashmere Goat Induced Pluripotent Stem Cells in LCDM with Trophectoderm Lineage Differentiation and Interspecies Chimeric Abilities.
    Article Snippet: The primary antibodies were as follows: anti-NANOG (1:200; 500-P236, Peprotech); anti-SSEA1 (1:200; MAB4301, Santa Cruz Biotechnology, Dallas, TX, USA); anti-SSEA4 (1:200; MAB4304, Santa Cruz Biotechnology, Dallas, TX, USA); anti-EpCAM (1:200; ab71916, Abcam, Cambridge, UK); anti-CDX2 (1:200; #MU392A-UC, Biogenex, San Francisco, CA, USA); anti-AFP (1:200; MAB1368, R&D Systems, Minneapolis, MN, USA); anti-alpha smooth muscle actin (1:200; ab5694, Abcam, Cambridge, UK); anti-glial fibrillary acidic protein (1:200; Z0334, Dako, Carpinteria, CA, USA); anti-KRT18 (1:200; F4772, SigmaAldrich, St. Louis, MO, USA); anti-PL (1:200; ab15554, Abcam, Cambridge, UK); anti- Int.

    Article Title: Mixed-Lineage Leukemia 1 Inhibition Enhances the Differentiation Potential of Bovine Embryonic Stem Cells by Increasing H3K4 Mono-Methylation at Active Promoters.
    Article Snippet: The antibodies used in this experiment included anti-OCT4 (sc-5279, Santa Cruz Biotechnology, Shanghai, China), anti-SOX2 (L1D6A2, Cell Signaling, Boston, MA, USA), anti-NANOG (500-P236, Peprotech, Shanghai, China), anti-SSEA-1 (MAB4301, Sigma, Shanghai, China), anti-SSEA-4 (MAB4304, Millipore, Shanghai, China), anti-TRA-1-60 (MAB4360, Shanghai, China), anti-TRA-1-81 (MAB4381, Shanghai, China), anti-AFP (AF5369, R&D Systems, Minneapolis, MN, USA), anti-SMA (ab5694, Abcam, Cambridge, MU, USA) and anti-GFAP (I1044, DAKO, Copenhagen, Denmark).

    Article Title: Mixed-Lineage Leukemia 1 Inhibition Enhances the Differentiation Potential of Bovine Embryonic Stem Cells by Increasing H3K4 Mono-Methylation at Active Promoters.
    Article Snippet: The antibodies used in this experiment included anti-α-SMA (ab244177, Abcam, Cambridge, MU, USA), anti-AFP (MAB1368, R&D Systems, Minneapolis, MN, USA) and anti-GFAP (Z0334, DAKO, Copenhagen, Denmark).

    Article Title: Mixed-Lineage Leukemia 1 Inhibition Enhances the Differentiation Potential of Bovine Embryonic Stem Cells by Increasing H3K4 Mono-Methylation at Active Promoters
    Article Snippet: The antibodies used in this experiment included anti-OCT4 (sc-5279, Santa Cruz Biotechnology, Shanghai, China), anti-SOX2 (L1D6A2, Cell Signaling, Boston, MA, USA), anti-NANOG (500-P236, Peprotech, Shanghai, China), anti-SSEA-1 (MAB4301, Sigma, Shanghai, China), anti-SSEA-4 (MAB4304, Millipore, Shanghai, China), anti-TRA-1-60 (MAB4360, Shanghai, China), anti-TRA-1-81 (MAB4381, Shanghai, China), anti-AFP (AF5369, R&D Systems, Minneapolis, MN, USA), anti-SMA (ab5694, Abcam, Cambridge, MU, USA) and anti-GFAP (I1044, DAKO, Copenhagen, Denmark).

    Incubation:

    Article Title: Enhanced innate responses in microglia derived from retinoblastoma patient-specific iPSCs.
    Article Snippet: Correspondence Zi-Bing Jin, Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730 China.. Email: jinzibing@foxmail.com Abstract RB1 deficiency leads to retinoblastoma (Rb), the most prevalent intraocular malignancy.. Tumor-associated macrophages (TAMs) are related to local inflammation disorder, particularly by increasing cytokines and immune escape.



    Similar Products

    afp  (Bioss)
    90
    Bioss afp
    Afp, supplied by Bioss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+afp/AFP+(A2)+Monoclonal+Antibody/10__1038_slash_s42003___026___11116___9-443-46-49
    Average 90 stars, based on 1 article reviews
    afp - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    93
    R&D Systems afp
    Afp, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+afp/Human%2FMouse+alpha-Fetoprotein%2FAFP+Antibody/pm42988810-359-38-42
    Average 93 stars, based on 1 article reviews
    afp - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology afp
    Afp, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+afp/AFP+Antibody/pm42843545-95-10-13
    Average 94 stars, based on 1 article reviews
    afp - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology ab_262054 mouse anti-afp
    Ab 262054 Mouse Anti Afp, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+afp/AFP+Antibody/pm42854559-53-98-102
    Average 94 stars, based on 1 article reviews
    ab_262054 mouse anti-afp - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Proteintech anti afp antibody
    Anti Afp Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+afp/AFP+Antibody/10__1038_slash_s41419___026___09209___8-269-8-19
    Average 94 stars, based on 1 article reviews
    anti afp antibody - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Alomone Labs guinea pig polyclonal anti gfap
    s‐GO:NPY prevents cLTP in dissociated amygdala cultures. (A) Representative fluorescence microscopy images of cultured amygdala cells showing the labelling for β‐tubulin III‐positive neurons (in red) and neuropeptide Y receptors (in green) type 1 (NPY1; top) and type 2 (NPY2; bottom). In blue, <t>GFAP‐positive</t> astrocytes. (B) Sketch of the experimental setting. While recorded with a patch‐clamp pipette in voltage‐clamp mode, neurons were treated with NPY or s‐GO:NPY 5 min before and during the protocol to induce cLTP. This consisted in a 30 s‐long lasting application of glutamate (50 u m ) during membrane potential depolarization to positive values. (C) Representative traces of recordings performed pre‐ and post‐ treatments. Note that the increment of EPSCs amplitude after cLTP induction (in blue) was prevented by the application of s‐GO:NPY (in orange) or NPY (in green). Bar plots of normalized EPSC amplitudes (D) and frequency (E) measured in a time window 18–24 min post‐cLTP. The application of NPY or s‐GO:NPY co‐applied to cLTP rescued the increased normalized EPSCs amplitudes observed in cLTP‐treated cells, while the EPSC frequency was not affected. No changes in EPSCs amplitude (1.16 ± 0.23) and frequency (0.87 ± 0.09) were found in saline‐treated cells ( n = 10 cells). * p <0.05.
    Guinea Pig Polyclonal Anti Gfap, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+afp/Guinea+Pig+Anti-GFAP+Antibody/pmc13426394-188-12-16
    Average 94 stars, based on 1 article reviews
    guinea pig polyclonal anti gfap - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Alomone Labs guinea pig polyclonal nti gfap
    s‐GO:NPY prevents cLTP in dissociated amygdala cultures. (A) Representative fluorescence microscopy images of cultured amygdala cells showing the labelling for β‐tubulin III‐positive neurons (in red) and neuropeptide Y receptors (in green) type 1 (NPY1; top) and type 2 (NPY2; bottom). In blue, <t>GFAP‐positive</t> astrocytes. (B) Sketch of the experimental setting. While recorded with a patch‐clamp pipette in voltage‐clamp mode, neurons were treated with NPY or s‐GO:NPY 5 min before and during the protocol to induce cLTP. This consisted in a 30 s‐long lasting application of glutamate (50 u m ) during membrane potential depolarization to positive values. (C) Representative traces of recordings performed pre‐ and post‐ treatments. Note that the increment of EPSCs amplitude after cLTP induction (in blue) was prevented by the application of s‐GO:NPY (in orange) or NPY (in green). Bar plots of normalized EPSC amplitudes (D) and frequency (E) measured in a time window 18–24 min post‐cLTP. The application of NPY or s‐GO:NPY co‐applied to cLTP rescued the increased normalized EPSCs amplitudes observed in cLTP‐treated cells, while the EPSC frequency was not affected. No changes in EPSCs amplitude (1.16 ± 0.23) and frequency (0.87 ± 0.09) were found in saline‐treated cells ( n = 10 cells). * p <0.05.
    Guinea Pig Polyclonal Nti Gfap, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+afp/Guinea+Pig+Anti-GFAP+Antibody/pm42535973-193-13-17
    Average 94 stars, based on 1 article reviews
    guinea pig polyclonal nti gfap - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Alomone Labs gfap
    s‐GO:NPY prevents cLTP in dissociated amygdala cultures. (A) Representative fluorescence microscopy images of cultured amygdala cells showing the labelling <t>for</t> <t>β‐tubulin</t> III‐positive neurons (in red) and neuropeptide Y receptors (in green) type 1 (NPY1; top) and type 2 (NPY2; bottom). In blue, <t>GFAP‐positive</t> astrocytes. (B) Sketch of the experimental setting. While recorded with a patch‐clamp pipette in voltage‐clamp mode, neurons were treated with NPY or s‐GO:NPY 5 min before and during the protocol to induce cLTP. This consisted in a 30 s‐long lasting application of glutamate (50 u m ) during membrane potential depolarization to positive values. (C) Representative traces of recordings performed pre‐ and post‐ treatments. Note that the increment of EPSCs amplitude after cLTP induction (in blue) was prevented by the application of s‐GO:NPY (in orange) or NPY (in green). Bar plots of normalized EPSC amplitudes (D) and frequency (E) measured in a time window 18–24 min post‐cLTP. The application of NPY or s‐GO:NPY co‐applied to cLTP rescued the increased normalized EPSCs amplitudes observed in cLTP‐treated cells, while the EPSC frequency was not affected. No changes in EPSCs amplitude (1.16 ± 0.23) and frequency (0.87 ± 0.09) were found in saline‐treated cells ( n = 10 cells). * p <0.05.
    Gfap, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+afp/Guinea+Pig+Anti-GFAP+Antibody/pmc13426394-184-15-16
    Average 94 stars, based on 1 article reviews
    gfap - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Alomone Labs anti gfap
    s‐GO:NPY prevents cLTP in dissociated amygdala cultures. (A) Representative fluorescence microscopy images of cultured amygdala cells showing the labelling <t>for</t> <t>β‐tubulin</t> III‐positive neurons (in red) and neuropeptide Y receptors (in green) type 1 (NPY1; top) and type 2 (NPY2; bottom). In blue, <t>GFAP‐positive</t> astrocytes. (B) Sketch of the experimental setting. While recorded with a patch‐clamp pipette in voltage‐clamp mode, neurons were treated with NPY or s‐GO:NPY 5 min before and during the protocol to induce cLTP. This consisted in a 30 s‐long lasting application of glutamate (50 u m ) during membrane potential depolarization to positive values. (C) Representative traces of recordings performed pre‐ and post‐ treatments. Note that the increment of EPSCs amplitude after cLTP induction (in blue) was prevented by the application of s‐GO:NPY (in orange) or NPY (in green). Bar plots of normalized EPSC amplitudes (D) and frequency (E) measured in a time window 18–24 min post‐cLTP. The application of NPY or s‐GO:NPY co‐applied to cLTP rescued the increased normalized EPSCs amplitudes observed in cLTP‐treated cells, while the EPSC frequency was not affected. No changes in EPSCs amplitude (1.16 ± 0.23) and frequency (0.87 ± 0.09) were found in saline‐treated cells ( n = 10 cells). * p <0.05.
    Anti Gfap, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+afp/Guinea+Pig+Anti-GFAP+Antibody/pmc13347764-109-34-37
    Average 94 stars, based on 1 article reviews
    anti gfap - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Alomone Labs polyclonal guinea pig anti gfap
    s‐GO:NPY prevents cLTP in dissociated amygdala cultures. (A) Representative fluorescence microscopy images of cultured amygdala cells showing the labelling <t>for</t> <t>β‐tubulin</t> III‐positive neurons (in red) and neuropeptide Y receptors (in green) type 1 (NPY1; top) and type 2 (NPY2; bottom). In blue, <t>GFAP‐positive</t> astrocytes. (B) Sketch of the experimental setting. While recorded with a patch‐clamp pipette in voltage‐clamp mode, neurons were treated with NPY or s‐GO:NPY 5 min before and during the protocol to induce cLTP. This consisted in a 30 s‐long lasting application of glutamate (50 u m ) during membrane potential depolarization to positive values. (C) Representative traces of recordings performed pre‐ and post‐ treatments. Note that the increment of EPSCs amplitude after cLTP induction (in blue) was prevented by the application of s‐GO:NPY (in orange) or NPY (in green). Bar plots of normalized EPSC amplitudes (D) and frequency (E) measured in a time window 18–24 min post‐cLTP. The application of NPY or s‐GO:NPY co‐applied to cLTP rescued the increased normalized EPSCs amplitudes observed in cLTP‐treated cells, while the EPSC frequency was not affected. No changes in EPSCs amplitude (1.16 ± 0.23) and frequency (0.87 ± 0.09) were found in saline‐treated cells ( n = 10 cells). * p <0.05.
    Polyclonal Guinea Pig Anti Gfap, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+afp/Guinea+Pig+Anti-GFAP+Antibody/pm42423189-113-32-41
    Average 94 stars, based on 1 article reviews
    polyclonal guinea pig anti gfap - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    s‐GO:NPY prevents cLTP in dissociated amygdala cultures. (A) Representative fluorescence microscopy images of cultured amygdala cells showing the labelling for β‐tubulin III‐positive neurons (in red) and neuropeptide Y receptors (in green) type 1 (NPY1; top) and type 2 (NPY2; bottom). In blue, GFAP‐positive astrocytes. (B) Sketch of the experimental setting. While recorded with a patch‐clamp pipette in voltage‐clamp mode, neurons were treated with NPY or s‐GO:NPY 5 min before and during the protocol to induce cLTP. This consisted in a 30 s‐long lasting application of glutamate (50 u m ) during membrane potential depolarization to positive values. (C) Representative traces of recordings performed pre‐ and post‐ treatments. Note that the increment of EPSCs amplitude after cLTP induction (in blue) was prevented by the application of s‐GO:NPY (in orange) or NPY (in green). Bar plots of normalized EPSC amplitudes (D) and frequency (E) measured in a time window 18–24 min post‐cLTP. The application of NPY or s‐GO:NPY co‐applied to cLTP rescued the increased normalized EPSCs amplitudes observed in cLTP‐treated cells, while the EPSC frequency was not affected. No changes in EPSCs amplitude (1.16 ± 0.23) and frequency (0.87 ± 0.09) were found in saline‐treated cells ( n = 10 cells). * p <0.05.

    Journal: Advanced Science

    Article Title: Neuropeptide Y—Graphene Oxide Complexes Inhibit Amygdala NPY‐Receptor Expressing Glutamatergic Pathways and Selectively Remove Aversive Memory In Vivo

    doi: 10.1002/advs.76608

    Figure Lengend Snippet: s‐GO:NPY prevents cLTP in dissociated amygdala cultures. (A) Representative fluorescence microscopy images of cultured amygdala cells showing the labelling for β‐tubulin III‐positive neurons (in red) and neuropeptide Y receptors (in green) type 1 (NPY1; top) and type 2 (NPY2; bottom). In blue, GFAP‐positive astrocytes. (B) Sketch of the experimental setting. While recorded with a patch‐clamp pipette in voltage‐clamp mode, neurons were treated with NPY or s‐GO:NPY 5 min before and during the protocol to induce cLTP. This consisted in a 30 s‐long lasting application of glutamate (50 u m ) during membrane potential depolarization to positive values. (C) Representative traces of recordings performed pre‐ and post‐ treatments. Note that the increment of EPSCs amplitude after cLTP induction (in blue) was prevented by the application of s‐GO:NPY (in orange) or NPY (in green). Bar plots of normalized EPSC amplitudes (D) and frequency (E) measured in a time window 18–24 min post‐cLTP. The application of NPY or s‐GO:NPY co‐applied to cLTP rescued the increased normalized EPSCs amplitudes observed in cLTP‐treated cells, while the EPSC frequency was not affected. No changes in EPSCs amplitude (1.16 ± 0.23) and frequency (0.87 ± 0.09) were found in saline‐treated cells ( n = 10 cells). * p <0.05.

    Article Snippet: The primary antibodies used were mouse polyclonal anti‐β‐tubulin III (Sigma, 1:250 dilution), guinea‐pig polyclonal anti GFAP (Alomone, 1:500 dilution), rabbit polyclonal anti‐NPY1 receptor (Abcam Plc, 1:500 dilution), and rabbit polyclonal anti‐NPY2 receptor (Thermofisher, dilution 1:2000).

    Techniques: Fluorescence, Microscopy, Cell Culture, Patch Clamp, Transferring, Membrane, Saline, Immunofluorescence

    s‐GO:NPY prevents cLTP in dissociated amygdala cultures. (A) Representative fluorescence microscopy images of cultured amygdala cells showing the labelling for β‐tubulin III‐positive neurons (in red) and neuropeptide Y receptors (in green) type 1 (NPY1; top) and type 2 (NPY2; bottom). In blue, GFAP‐positive astrocytes. (B) Sketch of the experimental setting. While recorded with a patch‐clamp pipette in voltage‐clamp mode, neurons were treated with NPY or s‐GO:NPY 5 min before and during the protocol to induce cLTP. This consisted in a 30 s‐long lasting application of glutamate (50 u m ) during membrane potential depolarization to positive values. (C) Representative traces of recordings performed pre‐ and post‐ treatments. Note that the increment of EPSCs amplitude after cLTP induction (in blue) was prevented by the application of s‐GO:NPY (in orange) or NPY (in green). Bar plots of normalized EPSC amplitudes (D) and frequency (E) measured in a time window 18–24 min post‐cLTP. The application of NPY or s‐GO:NPY co‐applied to cLTP rescued the increased normalized EPSCs amplitudes observed in cLTP‐treated cells, while the EPSC frequency was not affected. No changes in EPSCs amplitude (1.16 ± 0.23) and frequency (0.87 ± 0.09) were found in saline‐treated cells ( n = 10 cells). * p <0.05.

    Journal: Advanced Science

    Article Title: Neuropeptide Y—Graphene Oxide Complexes Inhibit Amygdala NPY‐Receptor Expressing Glutamatergic Pathways and Selectively Remove Aversive Memory In Vivo

    doi: 10.1002/advs.76608

    Figure Lengend Snippet: s‐GO:NPY prevents cLTP in dissociated amygdala cultures. (A) Representative fluorescence microscopy images of cultured amygdala cells showing the labelling for β‐tubulin III‐positive neurons (in red) and neuropeptide Y receptors (in green) type 1 (NPY1; top) and type 2 (NPY2; bottom). In blue, GFAP‐positive astrocytes. (B) Sketch of the experimental setting. While recorded with a patch‐clamp pipette in voltage‐clamp mode, neurons were treated with NPY or s‐GO:NPY 5 min before and during the protocol to induce cLTP. This consisted in a 30 s‐long lasting application of glutamate (50 u m ) during membrane potential depolarization to positive values. (C) Representative traces of recordings performed pre‐ and post‐ treatments. Note that the increment of EPSCs amplitude after cLTP induction (in blue) was prevented by the application of s‐GO:NPY (in orange) or NPY (in green). Bar plots of normalized EPSC amplitudes (D) and frequency (E) measured in a time window 18–24 min post‐cLTP. The application of NPY or s‐GO:NPY co‐applied to cLTP rescued the increased normalized EPSCs amplitudes observed in cLTP‐treated cells, while the EPSC frequency was not affected. No changes in EPSCs amplitude (1.16 ± 0.23) and frequency (0.87 ± 0.09) were found in saline‐treated cells ( n = 10 cells). * p <0.05.

    Article Snippet: The primary antibodies used were mouse polyclonal anti‐β‐tubulin III (Sigma, 1:250 dilution), guinea‐pig polyclonal anti GFAP (Alomone, 1:500 dilution), rabbit polyclonal anti‐NPY1 receptor (Abcam Plc, 1:500 dilution), and rabbit polyclonal anti‐NPY2 receptor (Thermofisher, dilution 1:2000).

    Techniques: Fluorescence, Microscopy, Cell Culture, Patch Clamp, Transferring, Membrane, Saline